Celemics, Inc. (KOSDAQ:331920)

Market Cap	24.00B
Revenue (ttm)	6.72B
Net Income (ttm)	12.27B
Shares Out	8.16M
EPS (ttm)	1,493.00
PE Ratio	1.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,625
Average Volume	16,391
Open	2,985.00
Previous Close	2,970.00
Day's Range	2,940.00 - 3,075.00
52-Week Range	2,805.00 - 10,400.00
Beta	0.82
RSI	33.50
Earnings Date	Mar 18, 2025

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920